HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. Jan 2012 - :1097-0142 [PMID:22252842] [Sharma A] [Koldovsky U] [Xu S] [Mick R] [Roses R] [Fitzpatrick E] [Weinstein S] [Nisenbaum H] [Levine BL] [Fox K] [Zhang P] [Koski G] [Czerniecki BJ]
A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer. Dec 2011 - :1537-4513 [PMID:22130160] [Koski GK] [Koldovsky U] [Xu S] [Mick R] [Sharma A] [Fitzpatrick E] [Weinstein S] [Nisenbaum H] [Levine BL] [Fox K] [Zhang P] [Czerniecki BJ]
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Feb 2007 - Cancer Res.; 67(4):0008-5472 [PMID:17293384] [Czerniecki BJ] [Koski GK] [Koldovsky U] [Xu S] [Cohen PA] [Mick R] [Nisenbaum H] [Pasha T] [Xu M] [Fox KR] [Weinstein S] [Orel SG] [Vonderheide R] [Coukos G] [DeMichele A] [Araujo L] [Spitz FR] [Rosen M] [Levine BL] [June C] [Zhang PJ]
